Senova Biotech (Shanghai) Co.,Ltd. – Trademark Portfolio
Entity Type: 99
Senova Biotech (Shanghai) Co.,Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 11 (Environmental Control) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SEAVOVA.
Room 268, Zone A, 2nd Floor, No. 2088 Songze Avenu
Xujing Town, Qingpu District 201702 Shanghai
Showing of trademarks Trademarks
Trademark Classifications
Senova Biotech (Shanghai) Co.,Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Frequently Asked Questions
How many trademarks does Senova Biotech (Shanghai) Co.,Ltd. have?
Senova Biotech (Shanghai) Co.,Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Senova Biotech (Shanghai) Co.,Ltd. file in?
Senova Biotech (Shanghai) Co.,Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 11 (Environmental Control). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Senova Biotech (Shanghai) Co.,Ltd.'s most well-known trademarks?
Senova Biotech (Shanghai) Co.,Ltd.'s registered trademark portfolio includes well-known marks such as SEAVOVA. These are among 1 currently registered trademark in the portfolio.
What is Senova Biotech (Shanghai) Co.,Ltd.'s trademark registration success rate?
Senova Biotech (Shanghai) Co.,Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.